Book
Licensed
Unlicensed
Requires Authentication
Technikfolgenabschätzung des CRISPR/Cas-Systems
Über die Anwendung in der menschlichen Keimbahn
-
Annika Hardt
Language:
German
Published/Copyright:
2019
About this book
OpusPrimum Gewinner 2019
Since the description of the CRISPR/Cas System as a potential “gene splicer” in 2012, the idea of precise alteration of the genome in human germ cells and embryos has seemed to come within reach. This book provides a profound risk-benefit presentation that considers both individual and societal aspects and offers a differentiated presentation of competing positions in the debate about this controversial intervention.
- Detailed critical examination of the arguments with analysis of the highly topical debate on germ line interventions
- With risk-benefit analysis taking into account individual as well as societal aspects
Topics
|
Publicly Available Download PDF |
I |
|
Publicly Available Download PDF |
V |
|
Publicly Available Download PDF |
VII |
|
Publicly Available Download PDF |
IX |
|
Requires Authentication Unlicensed Licensed Download PDF |
1 |
|
Requires Authentication Unlicensed Licensed Download PDF |
7 |
|
Requires Authentication Unlicensed Licensed Download PDF |
57 |
|
Requires Authentication Unlicensed Licensed Download PDF |
259 |
|
Requires Authentication Unlicensed Licensed Download PDF |
281 |
|
Requires Authentication Unlicensed Licensed Download PDF |
283 |
|
Requires Authentication Unlicensed Licensed Download PDF |
285 |
Publishing information
Pages and Images/Illustrations in book
eBook published on:
January 14, 2019
eBook ISBN:
9783110624472
Hardcover published on:
January 14, 2019
Hardcover ISBN:
9783110621709
Pages and Images/Illustrations in book
Front matter:
10
Main content:
312
Coloured Illustrations:
1
Audience(s) for this book
Biologen, Mediziner, Sozialwissenschafter, (Moral)Philosophen
Safety & product resources
-
Manufacturer information:
Walter de Gruyter GmbH
Genthiner Straße 13
10785 Berlin
productsafety@degruyterbrill.com
